Company Filing History:
6 out of 827 
1 out of 560 
1 out of 832,812 Years Active: 2006-2020
Title: Innovations and Contributions of Robert Brueggemeier
Introduction
Robert Brueggemeier is a notable inventor based in Dublin, Ohio, with a significant portfolio of seven patents. His work primarily focuses on the development of novel compounds that have potential applications in treating various diseases, particularly cancer.
Latest Patents
Among his latest patents are the Pyrrolopyrimidine derivatives as Mps1/TTK kinase inhibitors. This patent discloses novel compounds that act as Mps1/TTK inhibitors, along with compositions and methods for using these compounds in treating various diseases. Another significant patent is for heteroaryl-containing isoflavones as aromatase inhibitors. This patent provides compounds and methods useful for the treatment and prevention of cancer, especially hormone-dependent breast cancer. The patent outlines a method for synthesizing 2-substituted isoflavones, which involves several chemical reactions to produce the final compound.
Career Highlights
Robert Brueggemeier has had a distinguished career, contributing to the field of medicinal chemistry and drug development. He has worked at The Ohio State University, where he has likely collaborated with other researchers and contributed to various projects in the field.
Collaborations
Some of his notable coworkers include Young-Woo Kim and John C. Hackett. Their collaborations have likely enhanced the research and development of innovative compounds in the pharmaceutical field.
Conclusion
Robert Brueggemeier's contributions to the field of medicinal chemistry through his patents and collaborations highlight his significant role in advancing treatments for critical health issues. His innovative work continues to impact the medical community positively.